MedTrace Logo

Enteral Nutrition Product in Mild Acute Pancreatitis

NCT01249963 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-06-22

No results posted yet for this study

Summary

The aim of the study is to evaluate the beneficial effects of the administration of enteral nutrition product with milk proteins, monounsaturated fatty acids and low dextrose equivalent maltodextrin and enriched in eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and medium chain triglycerides (MCT) in patients with mild acute pancreatitis. All this against other specific product.

The main objectives of this project are:

* Comparing the tolerance of both preparations.
* Comparing the evolution of nutritional status in both groups.
* Comparing the evolution of inflammatory parameters in both groups

Conditions

Interventions

DIETARY_SUPPLEMENT

T-Diet plus Atémpero

T-Diet plus Atémpero is a complete normocaloric and normoproteic enteral nutrition product for the dietary management of patients with mild acute pancreatitis.

DIETARY_SUPPLEMENT

AlitraQ (Abbott)

AlitraQ is a nutritional product for patients with impaired gastrointestinal function.For oral or tube nutrition. Enriched with glutamine and arginine.

Sponsors & Collaborators

  • Vegenat, S.A.

    lead INDUSTRY

Principal Investigators

  • Pilar García-Peris, PhD · Hospital Universitario Gregorio Marañón

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2012-12-31
Completion
2013-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01249963 on ClinicalTrials.gov